Short Review| Volume 365, ISSUE 1, P109-113, January 2023

Pyo-pericardium secondary to bacteremia in intra-venous drug user

Published:September 16, 2022DOI:


      Pyo-pericardium is a collection of purulent fluid in the pericardial sac. It is a rare finding seen in less than 1% of patients who develop acute pericarditis. The condition, though uncommon, has a mortality risk of 100% in untreated patients and 40% in treated patients. Most of the reported cases in the literature describe the occurrence of pyo-pericardium in IV drug users that's secondary to needle fragment embolization to the pericardium diagnosed through an echocardiogram and CT scan with no evidence of bacteremia. Unlike reported cases, we present a case of pyo-pericardium in a 37-year-old woman with bacteremia from a wound infection on her leg secondary to IV drug use. Needle embolization was ruled out in our case as no foreign object was identified on echocardiography or CT scan. Prompt identification followed by aggressive treatment with pericardial window and systemic antibiotics is crucial for decreasing mortality in such high-risk patients.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cracknell B.R.S.
        • Ail D
        The unmasking of a pyopericardium.
        BMJ Case Rep. 2015; 2015 (bcr2014207441)
      1. Gopalakrishnan M., Manappallil R.G., Nambiar H., et al. Pyopericardium progressing to tamponade in a patient with immune thrombocytopenia. BMJ Case Rep. 2018;2018:bcr2018225009.

        • Rubin R.H.
        • Moellering Jr, R.C
        Clinical, microbiologic and therapeutic aspects of purulent pericarditis.
        Am J Med. 1975; 59: 68-78
        • Sagristà-Sauleda J.
        • Barrabés J.A.
        • Permanyer-Miralda G.
        • et al.
        Purulent pericarditis: review of a 20-year experience in a general hospital.
        J Am Coll Cardiol. 1993; 22: 1661-1665
        • Parikh S.V.
        • Memon N.
        • Echols M.
        • et al.
        Purulent pericarditis: report of 2 cases and review of the literature.
        Medicine (Baltimore). 2009; 88: 52-65
        • Little W.C.
        • Freeman G.L
        Pericardial disease.
        Circulation. 2006; 113 (Mar 28): 1622-1632
        • Hall I.P
        Purulent pericarditis.
        Postgrad Med J. 1989; 65: 444-448
        • Lavender T.W.
        • McCarron B
        Acute infections in intravenous drug users.
        Clin Med. 2013; 13: 511-513
        • Capizzi J.
        • Leahy J.
        • Wheelock H.
        • et al.
        Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018.
        PLoS One. 2020; 15e0242165
        • Pankuweit S.
        • Ristić A.D.
        • Seferović P.M.
        • et al.
        Bacterial pericarditis: diagnosis and management.
        Am J Cardiovasc Drugs. 2005; 5: 103-112
        • Basman C.
        • Patel Y.
        • Shalonov A.
        • et al.
        Epidemic of heroin: purulent pericardial effusion and septic emboli in an intravenous drug user with right sided endocarditis.
        B55 Crit Care Case Rep. 2017; (A3772-A3772)
        • Steiner J.
        • Dhingra R.
        • Devries J.T
        Needle in the haystack: purulent pericarditis from injection drug use.
        Catheter Cardiovasc Interv. 2012; 80 (Sep 1): 493-496
        • Kondapi D.
        • Markabawi D.
        • Chu A.
        • et al.
        Staphylococcal pericarditis causing pericardial tamponade and concurrent empyema.
        Case Rep Infect Dis. 2019; 2019 (2019/07/18)3701576